Molecular and Genetic Analysis of Lung Cancer
Status: Recruiting
Location: See all (2) locations...
Study Type: Observational
SUMMARY
RATIONALE: Studying samples of blood and tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help the study of cancer in the future. PURPOSE: This clinical trial is analyzing the DNA in blood and tissue samples from patients with lung cancer.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 120
Healthy Volunteers: t
View:
∙ DISEASE CHARACTERISTICS:
• Patient:
⁃ Newly diagnosed primary lung cancer
‣ Patient at Massachusetts General Hospital (MGH) or Boston Medical Center Cancer Center
∙ PATIENT CHARACTERISTICS:
• Not specified
∙ PRIOR CONCURRENT THERAPY:
• Not specified
Locations
United States
Massachusetts
Harvard School of Public Health
RECRUITING
Boston
Massachusetts General Hospital
RECRUITING
Boston
Time Frame
Start Date: 2005-09
Estimated Completion Date: 2026-09
Related Therapeutic Areas
Sponsors
Leads: Massachusetts General Hospital
Collaborators: National Cancer Institute (NCI)